CROs offering Phase I Clinical Trials with Biologics (Monoclonal Antibodies)
23 published
23 published CROs match Phase I Clinical Trials and Biologics (Monoclonal Antibodies).
Locations in this set include United States, United Kingdom, China, Australia, Germany, and Poland.
Capabilities that show up most often in this set: Phase II Clinical Trials, Phase III Clinical Trials, Regulatory Affairs, Biostatistics & Statistical Programming, and Data Management & eClinical.
Matching companies
TigermedLeading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
Velocity Clinical ResearchIntegrated clinical research site organization operating 60+ sites across the U.S. and Europe, supporting trials that contributed to 61 FDA-approved products since 1986.
WuXi AppTecGlobal CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.
Markdown mirror: /explore/phase-1-clinical-trials/biologics-monoclonal-antibodies.md